JMI Syringes & Medical Devices (DHA:JMISMDL) Total Stockholders Equity: BDT2,493 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:JMISMDL JMI Syringes & Medical Devices Ltd DHA:JMISMDL
75 GF Score
Price BDT132.70
View Full Analysis

What is JMI Syringes & Medical Devices Total Stockholders Equity?

JMI Syringes & Medical Devices DHA:JMISMDL -0.08% 75 Total Stockholders Equity is BDT2,493 Mil as of Mar. 2026. GuruFocus rates DHA:JMISMDL with a GF Score™ of 75/100.

JMI Syringes & Medical Devices's Total Stockholders Equity for the quarter that ended in Mar. 2026 was BDT2,493 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. JMI Syringes & Medical Devices's Book Value per Share for the quarter that ended in Mar. 2026 was BDT82.93. The ratio of a company's debt over equity can be used to measure how leveraged this company is. JMI Syringes & Medical Devices's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.01.

JMI Syringes & Medical Devices  (DHA:JMISMDL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

JMI Syringes & Medical Devices's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2492.61071818-0)/30.056
=82.93

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

JMI Syringes & Medical Devices's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(25.464401 + 0) / 2492.61071818
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices Total Stockholders Equity Related Terms

JMI Syringes & Medical Devices Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for JMI Syringes & Medical Devices's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices Total Stockholders Equity Chart

JMI Syringes & Medical Devices Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,699.46 2,733.76 2,583.79 2,592.62 2,609.66

JMI Syringes & Medical Devices Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,615.95 2,609.66 2,594.76 2,564.37 2,492.61
DHA:JMISMDL
75GF Score
JMI Syringes & Medical Devices Ltd DHA:JMISMDL
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of BDT2,493 Mil mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a Total Stockholders Equity of BDT2,493 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for JMI Syringes & Medical Devices and its competitors.
Is JMI Syringes & Medical Devices' Total Stockholders Equity too high?
JMI Syringes & Medical Devices' current Total Stockholders Equity is BDT2,493 Mil. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' Total Stockholders Equity compare to ISRG and BDX?
JMI Syringes & Medical Devices' Total Stockholders Equity of BDT2,493 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for JMI Syringes & Medical Devices and its competitors. JMI Syringes & Medical Devices's current Total Stockholders Equity is BDT2,493 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current Total Stockholders Equity of BDT2,493 Mil. The current Total Stockholders Equity is BDT2,493 Mil. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current Total Stockholders Equity is BDT2,493 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JMI Syringes & Medical Devices Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score

Get the complete analysis for DHA:JMISMDL

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT132.70
Price